CLOMINOVA
CLOMINOVA Tablet by NovaTech Sciences contains Clomiphene (CAS 50‑41‑9). Trusted manufacturer, supplier, and exporter of pharmaceutical‑grade hormone support for fertility, estrogen modulation, and reproductive wellness.
CAS Number: 50-41-9
CLOMINOVA is indicated for Post Cycle Therapy (PCT) to support natural testosterone recovery, maintain muscle gains, and regulate hormone levels after anabolic steroid cycles. It is widely used by athletes and bodybuilders to reduce side effects associated with steroid withdrawal and improve overall hormonal balance.
CLOMINOVA by Nova Techsciences is presented as an oral tablet containing Clomiphene Citrate 50 mg. Clomiphene, also written as clomifene in UK medical references, is an ovulation-stimulating medicine identified by CAS Number 50-41-9. It belongs to the selective oestrogen receptor modulator category and is used in authorised medical settings for certain cases of ovulatory failure in women who wish to become pregnant.
CLOMINOVA should only be supplied or used according to applicable prescription requirements and professional medical guidance. Before treatment is considered, other possible causes of infertility should be assessed, including thyroid, adrenal, pituitary, uterine and male-factor conditions.
CLOMINOVA Product Overview
- Product name: CLOMINOVA
- Active compound: Clomiphene Citrate
- Strength: 50 mg per tablet
- Dosage form: Oral tablet
- CAS Number: 50-41-9
- Brand: Nova Techsciences
The product label should clearly state the complete composition, excipients, tablet quantity, batch number, manufacturing date, expiry date and approved storage conditions. Information published online should match the packaging, Certificate of Analysis and authorised product documentation.
Quality and Product Traceability
A dependable CLOMINOVA product profile should be supported by documented quality controls. These may include raw-material identification, active-ingredient assay, content-uniformity testing, dissolution analysis, impurity assessment, microbiological testing and packaging-integrity checks.
Each manufactured batch should have a unique identification number linked to its production and laboratory-release records. Claims concerning pharmaceutical quality, purity or manufacturing standards should only appear when supporting evidence is current and verifiable.
For the United Kingdom, Netherlands and other European markets, the page should clearly communicate the product’s marketing-authorisation status, prescription category, responsible manufacturer and adverse-event reporting process.
Important Safety Information
Clomiphene treatment requires medical monitoring. Reported risks include ovarian enlargement, ovarian hyperstimulation syndrome, pelvic discomfort, visual disturbances and an increased possibility of multiple pregnancy. The medicine should not be used during pregnancy and may be unsuitable for people with liver disease, unexplained uterine bleeding, certain ovarian cysts or uncontrolled thyroid or adrenal conditions.
CLOMINOVA must not be promoted for unsupervised hormone management, performance enhancement or post-cycle use. Patients should discuss all medicines, supplements, fertility treatments and existing medical conditions with a qualified prescriber.
Related Nova Techsciences Products
ENCLOMINOVA
ENCLOMINOVA contains Enclomiphene Citrate, identified by CAS Number 7599-79-3. Although chemically related to clomiphene, enclomiphene is a distinct compound and requires separate regulatory, clinical and safety assessment. Its authorised status should be verified in every country where information is published.
FEMANOVA
FEMANOVA contains Letrozole 2.5 mg, associated with CAS Number 112809-51-5. Letrozole is an aromatase inhibitor authorised for specific hormone-dependent breast-cancer treatments in postmenopausal patients. It is not interchangeable with clomiphene and carries separate pregnancy, bone-health, liver and kidney precautions.
HALONOVA
HALONOVA contains Fluoxymesterone, identified by CAS Number 76-43-7. Fluoxymesterone is an androgenic and anabolic compound with important liver, cardiovascular, hormonal and reproductive safety concerns. Its product information should include clear contraindications and strong warnings against unsupervised or performance-related use.
NOVA-T3
NOVA-T3 is presented as a Liothyronine Sodium thyroid-hormone product associated with CAS Number 55-06-1. Liothyronine is used in selected thyroid disorders under medical supervision. It should not be presented as a general weight-loss or metabolism-enhancing product.
NOVA-T4
NOVA-T4 is presented within the thyroid-hormone range. CAS Number 55-03-8 is associated with levothyroxine, but the exact salt form, strength and regulatory details should be checked against the approved label. Thyroid replacement products require individual monitoring and accurate strength identification.
CLOMINOVA should ultimately be presented through accurate chemical identification, transparent batch documentation, balanced safety information and clearly stated regulatory status.
Important Information & FAQs
Precautions & Contraindications
Precautions
- Use only under medical supervision.
- Follow prescribed dosage and cycle length.
- Avoid self-medication.
- Consult your doctor if taking other medications, fertility drugs, or steroids.
- Keep out of reach of children.
- Discontinue and seek medical attention if vision changes, severe mood swings, or pelvic pain occur.
Contraindications
- Do not use if allergic to Clomiphene Citrate or inactive ingredients.
- Not recommended for individuals with liver disease, ovarian cysts (other than PCOS), abnormal uterine bleeding, or uncontrolled thyroid/adrenal disorders.
- Avoid alcohol and hormone supplements that may interfere with therapy.
- Pregnant women or individuals with hormone-dependent cancers should not use CLOMINOVA.
Related Products
AROMANOVA
High-potency Exemestane tablets for advanced estrogen control and PCT support.
CABERNOVA
Premium Cabergoline tablets for prolactin control, hormone support, and enhanced recovery.
ENCLOMINOVA
Premium Enclomiphene Citrate tablets for testosterone boosting, PCT recovery, and hormonal balance.
FEMANOVA
High-purity aromatase inhibitor for reliable estrogen control.